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Interferon-g (IFN-g) plays an important role in intestinal barrier dysfunction. However, the mechanisms are not
fully understood. As hypoxia-inducible factor-1 (HIF-1) is a critical determinant response to hypoxia and in-
flammation, which has been shown to be deleterious to intestinal barrier function, we hypothesized that IFN-g
induces loss of barrier function through the regulation of HIF-1a activation and function. In this study, we
detected the expressions of HIF-1a and tight junction proteins in IFN-g-treated T84 intestinal epithelial cell line.
IFN-g led to an increase of HIF-1a expression in time- and dose-dependent manners but did not change the
expression of HIF-1b. The IFN-g-induced increase in HIF-1a was associated with an activation of NF-kB.
Treatment with the NF-kB inhibitor, pyrolidinedithiocarbamate (PDTC), significantly suppressed the activation
of NF-kB and the expression of HIF-1a. In addition, IFN-g also increased intestinal epithelial permeability and
depletion of tight junction proteins; inhibition of NF-kB or HIF-1a prevented the increase in intestinal perme-
ability and alteration in tight junction protein expressions. Interestingly, we demonstrated that a significant
portion of IFN-g activation NF-kB and modulation tight junction expression is mediated through HIF-1a. Taken
together, this study suggested that IFN-g induced the loss of epithelial barrier function and disruption of tight
junction proteins, by upregulation of HIF-1a expression through NF-kB pathway.
Introduction
The main function of the human intestinal epithelia is toallow the absorption of nutrients while also functioning
as a barrier, which prevents foreign antigens and pathogens
entering the mucosal tissues and potentially causing disease.
Tight junctions and its associated proteins, including zonu-
laoccludens, occludin and claudins, and so on, are theapical-
most adhesive junctional complexes and act as a structural
and functional barrier against paracellular permeation of
luminal substances (Groschwitz and Hogan 2009; Ullu-
wishewa and others 2011). A breakdown or impairment of
the epithelial barrier has been implicated as a critical deter-
minant in the predisposition to intestinal inflammation and a
number of inflammatory disorders, such as inflammatory
bowel disease (Suenaert and others 2002), food allergy
(Ventura and others 2006), celiac disease (Diraimondo and
others 2012). Although the mechanisms of intestinal barrier
dysfunction involved in these diseases are incompletely un-
derstood, proinflammatory cytokines have been shown to
play important roles in these processes. For example, inter-
feron-g (IFN-g), tumor necrosis factor-a (TNF-a) and lipo-
polysaccharide (LPS) as well as interleukins (IL), which are
central mediators of intestinal inflammatory diseases, induce
the loss of intestinal epithelial barrier function (Youakim and
Ahdieh 1999; Suenaert and others 2002; Bruewer and others
2003; Prasad and others 2005; Wang and others 2005; Ye and
others 2006; Al-Sadi and Ma 2007; Wisner and others 2008;
Capaldo and Nusrat 2009; Groschwitz and Hogan 2009; He
and others 2012; Guo and others 2013). In addition, our
previous studies demonstrated that IFN-g evokes epithelial
cell apoptosis and impairs intestinal barrier function (Yang
and others 2002, 2003). Although the precise mechanisms
involved in intestinal barrier dysfunction induced by proin-
flammatory cytokines are still unclear, it has been well
demonstrated that the NF-kB pathway plays an important
role in this cytokine-induced intestinal barrier dysfunction
(Boivin and others 2009; Dehne and Brune 2009).
Hypoxia-inducible factor-1 alpha (HIF-1a) has emerged as
a central determinant in the pathophysiological response to
cellular hypoxia (Semenza 2001, 2007). HIF is a heterodimer
of bHLH-PAS proteins and consists of oxygen-regulated al-
pha subunit (such as HIF-1a) and a constitutively expressed
beta subunit (such as HIF-1b, also called ARNT1) that binds
DNA at specific locations termed hypoxia response elements
(HREs) (Kaelin and Ratcliffe 2008); its activation is
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dependent on the stabilization of an oxygen-sensitive deg-
radation pathway that is regulated by a family of prolyl
hydroxylase (PHD) enzymes. Previous studies have indi-
cated that HIF-1a plays an important role in the majority of
clinically relevant hypoxic/ischemic episodes and human
cancers (Toiyama and others 2010; Nam and others 2011;
Hiraki and others 2012). Recent studies have showed that
HIF-1a activation is deleterious to intestinal barrier function
associated with hypoxia, ischemia/reperfusion, and inflam-
mation (Rosenberger and others 2007; Feinman and others
2010; Kannan and others 2011; Liu and others 2011).
Recently, induction of HIF-1a by proinflammatory cyto-
kines, not only under hypoxia but also under normoxic
conditions, has been described in numbers of studies ( Jung
and others 2003; Frede and others 2005; Belaiba and others
2007; Peyssonnaux and others 2007). Many of the stimuli that
induce HIF-1 in normoxia are known to activate a number of
other transcription factors such as NF-kB (Taylor 2008). In
addition, the HIF-1a promoter contains an active NF-kB
binding site in a position - 197/188 upstream of the tran-
scription start site (van Uden and others 2008). Importantly,
studies have demonstrated that the NF-kB can be activated
by IFN-g (Gough and others 2008; Lin and others 2012).
Since IFN-g and HIF-1a play important roles in intestinal
barrier dysfunction, and NF-kB could be activated by IFN-g,
we asked the relationship of these 2 factors in this process.
For this purpose, we aimed to clarify if epithelial-derived
HIF-1a activation and function are regulated by IFN-g. Our
data indicated that IFN-g activates the NF-kB pathway,
which, in turn, leads to the activation of HIF-1a; and HIF-1a
play a major mechanistic role in IFN-g-induced intestinal
barrier dysfunction. Taken together, our finding, for the first
time, reveals that IFN-g induces intestinal epithelial barrier
dysfunction through NF-kB/HIF-1a pathway.
Materials and Methods
Materials
IFN-g was purchased from Novoprotein. HIF-1a inhibitor
YC-1 was purchased from Sigma. The inhibitor of NF-kB
pyrolidinedithiocarbamate (PDTC), Nuclear and Cyto-
plasmic Protein Extraction Kit, and anti-H3 antibody were
purchased from Beyotime. Anti-p65, anti-IkBa, anti-P-IkBa,
anti-ZO-1, and anti-Occludin antibodies were purchased
from Santa Cruz Biotechnology, Inc. Anti-GAPDH antibody
was purchased from Goodhere Biotechnology. Anti-HIF-1a,
anti-HIF-1b, anti-Claudin-1, anti-Claudin-2 antibodies were
purchased from Abcam or Proteintech.
Cell culture
T84 intestinal epithelial cells were purchased from China
Center for Type Culture Collection and maintained at 37C
in 1:1 DMEM/Ham’s F-12 medium supplemented with10%
fetal bovine serum (Gemini Bioproducts) and 100U/100mg/
mL penicillin and streptomycin (Invitrogen). The cells were
kept at 37C in a 5% CO2 environment. Culture medium was
changed every 2 days. T84 cells were subcultured after par-
tial digestion with 0.25% trypsin and 0.53mM EDTA in
Hank’s balanced saline solution (HBSS) without Ca2 + and
Mg2 + . Unless stated otherwise, in all experiments, IFN-gwas
added to the basolateral compartment only and control
monolayers were incubated with the cell culture medium.
RNA isolation and real-time quantitative RT-PCR
Total RNA was isolated using a Trizol reagent (TaKaRa)
according to the manufacturer’s protocol and quantified by
NanoDrop 2000 (Thermo). Reverse transcription of the RNA
was performed by using a PrimeScript RT reagent kit (Ta-
KaRa) according to the manufacturer’s instructions. Real-time
quantitative RT-PCR (qRT-PCR) was performed on 50ng
cDNA template, using Rotor-Gene Q (Qiagen) and the SYBR
Premix Ex TaqTM II (TaKaRa), in a total volume of 20mL. The
PCR was performed as follows: denaturation at 94C for 10 s,
annealing at 60C for 15 s, and elongation at 72C for 20 s, for a
total of 40 cycles. Primer sequences used in this study are
designed as follows: HIF-1a (forward 5¢-GCCGCTGGAGA
CACAATCATA-3¢ and reverse 5¢-GGTGAGGGGAGCATTA
CATCAT-3¢) and b-actin (forward 5¢-CCACGAAACTACCTT
CAACTCC-3¢ and reverse 5¢-GTGATCTCCTTCTGCATC
CTG-3¢). All data were normalized using b-actin as reference
values and expressed as relative fold increases over control.
The amplification efficiency of HIF-1a and b-actin was *1.72
and the difference between them was lower than 0.02.
Measurement of transepithelial electrical resistance
Transepithelial electrical resistance (TER) values of mono-
layers grown on 0.33 cm2 Transwell supports were deter-
mined with a Millicell-ERS voltohmmeter (Millipore), and
TER measurements were calculated in Ohms cm2 (O(cm2) to
determine the TER of the epithelium alone (Wells and others
1998). To facilitate comparisons between conditions, TER was
normalized to initial value, and expressed as percentage of
initial resistance values.
Western blot analysis
The cells were washed twice with phosphate-buffered
saline (PBS) before lysis in cold RIPA buffer (PBS, 1% NP-40,
0.5% sodium deoxycholate, 0.1% SDS, 1 mg/mL APMSF,
1.0mM sodium orthovandate, 1·mammalian protease in-
hibitor cocktail; Sigma-Aldrich). Where indicated, nuclear
epithelial cell fractions were prepared using the Nuclear and
Cytoplasmic Protein Extraction Kit (Beyotime) according to
the manufacturer’s instructions. The protein concentration
was determined according to the Bradford method using
BCA assay reagent (Beyotime). Samples (25mg protein) were
loaded onto 8–12% SDS-PAGE, and the proteins were then
electrophoretical transferred to a polyvinylidene fluoride
membrane blocked by 5% bovine serum albumin (BSA) for
1 h at room temperature and then incubated with antibodies
overnight at 4C: anti-p65 (1:200), anti-IkBa (1:200), P-IkBa
(1:200), H3 (1:1,000), ZO-1 (1:500), Occludin (1:500), HIF-1a
(1:1,000), HIF-1b (1:2,000), Claudin-1 (1:1,000), Claudin-2
(1:1,000), and anti-GAPDH (1:1,000). The membranes were
then washed 3 times in TBST (50mM Tris-HCl pH7.5,
140mM NaCl, 0.1% Tween) and incubated with secondary
antibody at room temperature for 1 h. A enhanced chemi-
luminescence reagent, ECL Western blotting detection re-
agent (Boster), was used to make the labeled protein bands
to be detected with Image Station 4000R (Kodak).
Fluorescence microscopy
HIF-1a and cellular tight junction proteins: ZO-1, Occlu-
din, and Claudin-1 were assayed with an immunofluorescent
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technique. T84 monolayers were washed twice with PBS
before fixed with 4% paraformaldehyde for 15min at room
temperature, washed again, and permeabilized in for 10min
with 0.1% Triton X-100. The cells were blocked by 5% solu-
tion of BSA for 30min at room temperature and then incu-
bated with anti-HIF-1a (1:25), anti-ZO-1 (1:100), Occludin
(1:100), and Claudin-1 (1:200) antibodies diluted in PBS
containing 5% BSA at 4C overnight; monolayers were wa-
shed with PBS and incubated with Cy3 red-conjugated goat
anti-rabbit secondary antibodies (1:500; Boster) for 1 h in
dark conditions. They were then washed and mounted using
ProLong Gold antifade reagent with DAPI (Invitrogen).
Negative controls were also carried out omitting the primary
antibody. Monolayers were imaged using a laser scanning
fluorescence microscopy (Leica TCS SP5; Leica).
Statistical analyses
Statistical analyses were performed using SPSS 13.0 soft-
ware. All experimental data are shown as mean– SD. Com-
parisons among 3 or more groups were made by analysis of
variance (ANOVA), and the 2 groups were compared by
Student’s t-test. A P value less than 0.05 was considered
statistically significant in all cases. All reported significance
levels represent 2-tailed P values. If not otherwise stated, all
experiments were repeated at least 3 individual experiments
to ensure reproducibility.
Results
IFN-g induces HIF-1a expression in time-
and dose-dependent manners
Hypoxia-inducible factor 1 (HIF-1) is one of the master
regulators that orchestrate the cellular responses to hypoxia.
Even if the HIF-1 system evolved exclusively for the adap-
tation of organisms to hypoxia, recent studies show that both
HIF-1a protein abundance and HIF-1a transactivation
activity can also be induced under normoxic conditions in
response to various nonhypoxic stimuli, such as TNF-a and
IL-1b as well as LPS ( Jung and others 2003; Frede and others
2005; Peyssonnaux and others 2007). Moreover, these stim-
ulating factors play vital roles in the modulation of intestinal
barrier function disruption. Similarly, it has been shown that
IFN-g also plays a deleterious role in intestinal barrier
function (Youakim and Ahdieh 1999; Utech and others 2005;
Juuti-Uusitalo and others 2011). We hypothesized that one
mechanism by which IFN-g mediates a loss of intestinal
barrier function is by the activation of HIF-1a. To address
this, the effect of IFN-g on HIF-1a accumulation in intestinal
epithelial cells was investigated. T84 epithelial cells were
treated with 50 ng/mL IFN-g or vehicle and then subjected to
normoxia or hypoxia for 6 h. HIF-1a protein levels were ex-
amined by Western blot. As shown in Fig. 1A, there is no
significant change of HIF-1a expression of T84 epithelial cells
after 6 h treatment with IFN-g, whereas hypoxia treatment
for 6 h led to a dramatic increase of HIF-1a protein expres-
sion compared with controls. The HIF-1a protein expression
of T84 cells receiving hypoxia stimulation increased more
significantly than that receiving IFN-g stimulation (Fig. 1A).
The mechanism for this difference is not clear. It maybe that
IFN-g-induced increase in HIF-1a is a relatively slow process,
potentially requiring a more prolonged treatment of 24 h or
more (Gerber and others 2009).
Based on the results presented above, we next examined
whether IFN-g-induced HIF-1a are synchronized in time. T84
were treated with IFN-g (50ng/mL) for up to 48h, and the total
RNA and protein were harvested at the indicated times (0, 6, 12,
24, and 48h). As shown in Fig. 1B, a time-dependent increase of
HIF-1a mRNA was observed in the presence of IFN-g. The in-
crease inHIF-1amRNAwas not significant at earlier time points
(eg, at 6h) but became significant by 24 and 48h. We also de-
tected an increase in the levels of HIF-1a protein byWestern blot
at the indicated times of IFN-g treatment. HIF-1a protein ex-
pression was also induced in a time-dependent (Fig. 1C) manner
by IFN-gwith little to no induction occurring until 6h following
cytokine stimulation, after which levels of protein remained in-
creasing for up to 48h, and the change of HIF-1a protein is
consistent with the result of real-time quantitative PCR.
FIG. 1. Changes of hypoxia-inducible factor-1 alpha (HIF-1a) expression in T84 intestinal epithelial cells after interferon-g
(IFN-g) treatment. (A) T84 intestinal epithelial cells were treated with vehicle control, 50 ng/mL IFN-g, or hypoxia (1% O2) for
6 h, and HIF-1a protein expression were assayed. No significant changes of HIF-1a protein expression were found after T84
cells treated with IFN-g for 6 h, whereas hypoxia caused a dramatic increase in HIF-1a protein expression. (B) T84 cells were
treated with 50 ng/mL of IFN-g, and IFN-g caused a time-dependent increase in HIF-1a mRNA expression (B) and protein
expression (C). HIF-1a mRNA were calculated relative to b-actin and expressed as fold change relative to controls. (D) T84
cells were treated with different concentrations of IFN-g for 24 h, and IFN-g-induced HIF-1a expressions in a dose-dependent
manner. *P < 0.05 versus control. Data are representative of 3 similar experiments.
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We also detected different concentrations of IFN-g on the
expressions of HIF-1a. In T84 cells, IFN-g was found to in-
crease HIF-1a in a dose-dependent manner after 24 h of
treatment (Fig. 1D).
The expression of HIF-1b in T84 cells
is independent of IFN-g
It has been demonstrated that HIF-1 is a heterodimer of
bHLH-PAS proteins and consists of oxygen-regulated alpha
subunit and a constitutively expressed beta subunit (Kaelin
and Ratcliffe 2008). Because HIF-1a/HIF-1b hetero-
dimerization is required for the stable of HIF-1 and forma-
tion of the active transcriptional complex, we examined
whether the expression of HIF-1b was changed in IFN-g-
treated T84 cells. As shown in Fig. 2A and B, IFN-g did not
induce any changes of HIF-1b expression in a time- or dose-
dependent manner.
As HIF-1, plays biological activities, needs to bind with
DNA at specific locations termed HREs, we used immuno-
fluorescence staining to examine whether nuclear HIF-1a
was increased after treatment of IFN-g. As illustrated in Fig.
2C, compared with control, IFN-g increased the expression of
HIF-1a in nuclear, which indicated the activation of HIF-1.
IFN-g-induced HIF-1a expression is mediated
through NF-kB pathway activation
The interactions between proinflammatory cytokines and
elements of the HIF system have recently been observed in
several studies ( Jung and others 2003; Frede and others 2005;
Peyssonnaux and others 2007; Hot and others 2012). Cyto-
kines that activate NF-kB may increase HIF-1a expression by
driving increased transcription (Rius and others 2008). Re-
cently, several studies have demonstrated that the NF-kB can
be activated by IFN-g (Gough and others 2008; Lin and
others 2012). Therefore, to investigate the potential role of the
NF-kB pathway in the effects of IFN-g on T84 intestinal ep-
ithelial cells, cells were pretreated with the NF-kB inhibitor
PDTC, followed by the addition of IFN-g or vehicle control.
Levels of IkB family proteins and the NF-kB subunit protein
p65 were assayed in cytoplasmic and nuclear extracts of T84
monolayers treated with IFN-g. Figure 3A shows that IFN-g
treatment induced a significant increase in cytoplasmic levels
of phosphorylated IkB, with a concomitant decrease in IkB
levels. Consistent with this, at 12 h of IFN-g treatment, nu-
clear levels of active p65 NF-kB subunit were dramatically
increased, both of which indicate robust NF-kB activation,
whereas pretreatment with PDTC inhibited IFN-g-induced
nuclear translocation of p65 and decrease of IkB in cytoplasm
levels after 12 h of cytokine treatment.
To determine whether IFN-g-mediated NF-kB signaling is
required for the expression of HIF-1a, the NF-kB inhibitor
PDTC was added to T84 medium 1h before IFN-g treatment.
As shown in Fig. 3B, PDTC significantly inhibited IFN-g-
induced HIF-1a protein expression.
Blockade of either NF-kB activation
or HIF-1a attenuates IFN-g-induced
intestinal barrier dysfunction
To determine the effect of IFN-g on T84 intestinal epithelial
permeability, TER, a sensitive measure of barrier integrity, was
employed. Treatment of the cells with different doses of IFN-g
(0, 1, 10, 50, and 100ng/mL) added to the basolateral side of
the monolayer resulted in a dose-dependent decrease in TER
(Fig. 4A). The time course of IFN-g (50ng/mL) effect on T84
TER is shown in Fig. 4B. IFN-g caused a time-dependent drop
in T84 TER with a maximal drop occurring at 48h after treated
with IFN-g (Fig. 4B).
It has been shown that HIF-1a plays an important role in
intestinal barrier dysfunction (Rosenberger and others 2007;
Feinman and others 2010; Kannan and others 2011; Liu and
others 2011). To examine the interdependency of HIF-1a- on
IFN-g-induced intestinal barrier dysfunction, T84 cells was
FIG. 2. The expression of HIF-1b
in T84 cells is independent of IFN-g.
(A) T84 cells were treated with dif-
ferent concentrations of IFN-g, and
HIF-1b protein expressions were
assayed. IFN-g did not significantly
change the expression of HIF-1b.
(B) T84 cells were treated with IFN-
g (50 ng/mL) for 0, 6, 12, 24, and
48 h, HIF-1b is stably expressed
with time. (C) T84 cells were treated
with IFN-g (50 ng/mL) for 24 h, and
HIF-1a was analyzed by immuno-
fluorescence staining. Compared
with control, IFN-g induced signif-
icantly increase of HIF-1a in nu-
clear. Magnification: · 2000.
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pretreated with YC-1, a novel HIF-1a inhibitor, before IFN-g
treatment. As shown in Fig. 4C, the expression of HIF-1a
protein was concentration-dependently inhibited by YC-1
after 48 h treatment. YC-1 can also inhibit the IFN-g-induced
drop in T84 TER (Fig. 4D), indicating that HIF-1a activation
was required for the IFN-g-induced loss of epithelial barrier
function.
Blockade of either NF-kB activation or HIF-1a
attenuates disruption of tight junction proteins
induced by IFN-g treatment
Previous studies have demonstrated that IFN-g synergis-
tically disrupts intestinal mucosal morphology and impairs
intestinal epithelial barrier function by altering the expres-
sion and distribution of tight junction proteins (Youakim and
Ahdieh 1999; Bruewer and others 2005; Willemsen and oth-
ers 2005). In the following studies, we examined the mech-
anism by which HIF-1a is involved in IFN-g-induced
disruption in tight junction protein. Similar to previous re-
ports, IFN-g caused significant decrease in the expression
of tight junction proteins ZO-1 and Claudin-1 (Fig. 5A). IFN-
g also increased the expression of tight junction protein
Claudin-2, which has been shown to induce cation-selective
channels in the tight junction of epithelial cells, resulting in
increased paracellular permeability (Furuse and others 2001;
Amasheh and others 2002). However, no significant changes
were measured in Occludin expression after treated with
IFN-g. Importantly, pretreatment with the HIF-1a inhibitor
YC-1 significantly attenuates IFN-g-induced changes of these
tight junction protein expressions (Fig. 5B). Similarly, use of
the NF-kB inhibitor PDTC also attenuates the change of IFN-
g-induced tight junction proteins (Fig. 5A).
As cytokine-mediated disruption of epithelial tight junc-
tions can lead to either an internalization (ie, Occludin)
(Utech and others 2005) or absolute loss of these proteins (ie,
ZO-1) (Youakim and Ahdieh 1999), we next used immuno-
fluorescence staining to visualize the tight junction. No
staining was visible in any of the negative controls (date was
FIG. 3. NF-kB pathway activation is required for IFN-g to
regulate HIF-1a expression. (A) T84 cells were treated with
IFN-g (50 ng/mL) for the indicated time, and the ability of
IFN-g to activate the NF-kB signaling pathway was assayed
by measuring levels of cytoplasmic proteins (IkB, P-IkB,
p65) and nuclear NF-kB (p65) by Western immunoblot.
IFN-g treatment induced translocation of p65 from the cy-
toplasm to the nucleus in T84 cells. (B) T84 cells were
treated with 50 ng/mL IFN-g for 48 h. Treatment with IFN-
g caused a marked increase in HIF-1a protein expression,
whereas the NF-kB inhibitor pyrolidinedithiocarbamate
(PDTC) prevented the IFN-g induced increase of HIF-1a
expression. Data are representative of 3 similar experi-
ments.
FIG. 4. PDTC and YC-1 prevent
IFN-g-induced intestinal barrier
dysfunction. (A) T84 cells were
treated with different concentration
of IFN-g (0, 1, 10, 50, and 100 ng/
mL). IFN-g produced a dose-de-
pendent decrease in T84 transe-
pithelial electrical resistance (TER)
over the 48 h experimental period
(n = 4). *P < 0.05 versus control. (B)
50 ng/mL IFN-g was added to T84
cells for the indicated time. IFN-g
caused a time-dependent drop in
T84 TER (n = 4). *P< 0.05 versus
control. (C) T84 cells were cultured
with IFN-g (50 ng/mL) without or
with different doses (0, 1, 10, 50 mM)
of YC-1 for 48 h. IFN-g induced a
significant increase in HIF-1a pro-
tein expression, whereas YC-1 in-
hibited the IFN-g-induced increase
in HIF-1a expression at the con-
centration indicated. (D) NF-kB in-
hibitor PDTC (100 mM) and HIF-1a
inhibitor YC-1 (50mM) significantly
prevented the IFN-g (50ng/mL) in-
duced drop in T84 TER at 48h (n= 4)
*P< 0.05 versus controls. **P< 0.05
versus IFN-g-treated T84 cells.
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not shown). As illustrated in Fig. 6, at the site of control T84
monolayers, some tight junctions were bright, spherical ac-
cumulations of labeling, representing aggregations of junc-
tion proteins. However, T84 cells treated with IFN-g for 48 h
led to a dramatic disruption of tight junctions. Analysis of
IFN-g-treated T84 cells showed that immunostaining pattern
for ZO-1 and Claudin-1 was similar but of a decreased in-
tensity, with large portions of the junction appearing dark,
which represents discontinuities of tight junctions (Fig. 6).
Although no significant changes of Occludin protein ex-
pression were found after IFN-g treatment; however, the
morphologic distribution of Occludin became irregular and
was interrupted by gaps where tight junction proteins were
absent after IFN-g treatment (Fig. 6 insert image). As well, an
internalization of Occludin into the epithelial cell cytoplasm
was noted. By contrast, pretreatment with YC-1 (HIF-1a in-
hibitor) significantly attenuated the morphological changes
of tight junction protein ZO-1 and Occludin induced by IFN-
g (Fig. 6). Similarly, NF-kB inhibitor PDTC also attenuated
the morphological changes of tight junction proteins caused
FIG. 5. Effect of IFN-g on tight junction protein expression
in T84 cells. T84 cells were treated with vehicle, IFN-g
(50 ng/mL), or IFN-g and inhibitors PDTC or YC-1 for 48 h.
Protein expression were determined by Western immuno-
blot. IFN-g caused a downregulation of ZO-1 and Claudin-1
protein expressions, and IFN-g also induced an upregulation
of Claudin-2 protein expression, which plays an important
role in the loss of intestinal barrier function (A, B). While NF-
kB inhibitor PDTC (100 mM) (A) and HIF-1a inhibitor YC-1
(50 mM) (B) significantly attenuated the changes of IFN-g-
induced tight junction proteins.
FIG. 6. PDTCandYC-1attenuated IFN-g-induceddisruptionof tight junctionproteins.T84 cellswere treatedwith IFN-g (50ng/mL)
for 48h. Tight junction proteins ZO-1, Occludin, and Claudin-1 underwent immunofluorescence staining. IFN-g caused dramatic
disruption of tight junctions ZO-1 and Claudin-1. The large proportion of dark represents discontinuities of tight junctions. IFN-g also
caused disruption of the tight junction Occludin. As shown in the insert image, the distribution of Occludin was transformed from
regularly smooth into irregular, along with an internalization of the junctional protein. IFN-g induced morphological distribution of
tight junctions were inhibited by NF-kB inhibitor PDTC (100mM) or HIF-1a inhibitor YC-1 (50mM). Magnification:·800.
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by IFN-g (Fig. 6). These results indicate that HIF-1a plays an
integral role in IFN-g-induced intestinal barrier dysfunction.
Discussion
In the present study, we found that IFN-g-induced epi-
thelial barrier dysfunction by NF-kB/HIF-1a pathway. To
determine the roles of NF-kB and HIF-1a in IFN-g-induced
disruption in T84 intestinal epithelial barrier function, NF-kB
inhibitor PDTC and HIF-1a inhibitor YC-1 were used.
We found that PDTC significantly inhibit IFN-g-induced
activation of NF-kB. YC-1 as well as PDTC attenuates IFN-g-
induced HIF-1a expression and increase of TER. This study
also showed that IFN-g-induced disruption of tight junction
proteins were alleviated by PDTC and YC-1. Our study
provided new evidence for the mechanisms involved in IFN-
g-induced intestinal barrier dysfunction.
Previous studies have demonstrated that IFN-g plays
pivotal roles in the pathogenesis of intestinal barrier function
disruption (Youakim and Ahdieh 1999; Bruewer and others
2005; Willemsen and others 2005). In addition, we have
previously demonstrated that IFN-g evokes epithelial apo-
ptosis and impair intestinal barrier function (Yang and others
2002, 2003). However, the precise mechanism involved in is
still unclear. It has been well demonstrated that the NF-kB
pathway plays an important role in IFN-g-induced intesti-
nal barrier dysfunction (Boivin and others 2009). Further-
more, recent studies have shown that some biological
effects of IFN-g are elicited through activation of the NF-kB
pathway (Gough and others 2008; Thapa and others 2011;
Lin and others 2012). Therefore, in this study, we deter-
mined the potential role of the NF-kB pathway in the effects
of IFN-g-induced HIF-1a on T84 intestinal epithelial cells.
Our study demonstrates that IFN-g could activate NF-kB
through promoting the nucleus translocation of P65. It is
interesting to note that the IFN-g-induced NF-kB activation
demonstrated in this study is delayed in comparison to the
induction by other proinflammatory cytokines such as
TNF-a or LPS (Boivin and others 2009). It has been shown
that TNF-a-induced activation of NF-kB occurs almost im-
mediately following TNF-a treatment (Ma and others 2004;
Wang and others 2005). In this regard, the mechanism
mediating the IFN-g activation of NF-kB appears to be quite
distinct from that involved in TNF-a or LPS (Zhong and
others 2012).
Recent studies have demonstrated that increased HIF-1a
expressions are deleterious to intestinal or endothelial barrier
integrity (Rosenberger and others 2007; Feinman and others
2010; Kannan and others 2011; Liu and others 2011). Many of
the proinflammatory cytokines, such as TNF-a, LPS that in-
duce HIF-1 are known to activate a number of other tran-
scription factors such as NF-kB ( Jung and others 2003; Frede
and others 2005). As NF-kB is the key transcript factor for
HIF-1a expression (Figueroa and others 2002), therefore, we
hypothesized that IFN-g may induce the expression of HIF-
1a by NF-kB pathway. We found that IFN-g could upregu-
late HIF-1a expression in T84 intestinal epithelial cell lines,
and this increased HIF-1a expression could be efficiently
inhibited by NF-kB inhibitor PDTC, which suggested that
IFN-g increased HIF-1a expression was by the activation of
NF-kB transcription factor. In combination, our data indi-
cated that IFN-g activates NF-kB pathway, which, in turn,
leads to the expression of HIF-1a. This is the first study to
show that IFN-g-upregulated HIF-1a in T84 intestinal epi-
thelial cells is mediated by NF-kB pathway.
YC-1, a multifunctional agent, was first observed to be an
activator of platelet guanylate cyclase (Ko and others 1994).
More recently, YC-1 was reported to decrease hypoxia-
induced HIF-1a accumulation and expression (Chun and
others 2001; Sun and others 2007; Li and others 2008; Tsui
and others 2012). In the present study, we reveal that YC-1
attenuates intestinal epithelial barrier dysfunction caused by
IFN-g, as evidenced by that YC-1 mitigates TER decrease in
intestinal epithelia exposed to simultaneous IFN-g.YC-1 also
prevents IFN-g-induced disruption of intestinal tight junc-
tion, as evidenced by that YC-1 preserves the morphological
distribution of tight junction proteins ZO-1 and Occludin in
intestinal epithelia challenged with simultaneous IFN-g. In
support of our findings, previous studies have suggested
that YC-1 prevents barrier dysfunction and tight junction
protein ZO-1 and Occludin disorganization in endothelia
(Yeh and others 2007) or intestinal (Liu and others 2011).
Additionally, we have found that NF-kB inhibitor PDTC also
alleviates TER decrease and distribution of tight junction
proteins ZO-1, Occludin, Claudin-1, and Claudin-2 in T84
intestinal epithelial cells caused by IFN-g. Moreover, the ef-
fects of PDTC seem more significantly than YC-1. One most
possible reason is that YC-1 inhibits HIF-1a by attenuating
the activation of NF-kB. It has been reported YC-1 sup-
presses HIF-1 accumulation and translational upregulation
through inhibition of NF-kB signaling during hypoxia (Sun
and others 2007). Another possibility is that the activation of
NF-kB may play other deleterious roles in IFN-g-induced
intestinal barrier function disruption by other signal path-
ways, such as NF-kB/MLCK pathway (Ma and others 2005;
Gu and others 2011; He and others 2012). Further studies are
needed to fully delineate the intracellular mechanisms that
mediate NF-kB modulation of tight junction barrier follow-
ing IFN-g stimulation, and the role of NF-kB in the process of
YC-1 inhibition HIF-1a. The siRNA of NF-kB and HIF-1a
should be used to determine the precise mechanism involved
in IFN-g-induced intestinal epithelial barrier dysfunction in
our future studies.
In conclusion, IFN-g-induced disruption in epithelial
barrier function is regulated by NF-kB/HIF-1a pathway. To
the best of our knowledge, the current findings, for the first
time, demonstrate that IFN-g-induced activation of NF-kB
leads to a sequential activation of HIF-1a pathway and HIF-
1a plays an injurious role in IFN-g-induced epithelial bar-
rier dysfunction. The inhibition of NF-kB and HIF-1a
pathways attenuate intestinal epithelial barrier dysfunction
caused by proinflammatory cytokine IFN-g and prevent
IFN-g-induced morphological disruption of tight junction
in intestinal epithelia. Taken together, this study provides
new insight into the intracellular pathways that mediate the
IFN-g-induced disturbance of intestinal epithelial barrier
function.
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